// App-Quantinova.ai

2503.0 : The role of tumor markers for relapse detection in central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pool analysis of cooperative group clinical trials.

Researchers

Presenter

  • Adriana Fonseca

Principal Investigators

  • Cecile Faure-Conter

  • Matthew Murray

  • Jason R. Fangusaro

  • Stewart Goldman

  • Shivani Bailey

  • Gabriele Calaminus

  • Soumen Khatua

  • Didier Frappaz

  • Girish Dhall

  • James Nicholson

  • Eric Bouffet

  • Ute Katharina Bartels

Medical Centers

  • Hospital for Sick Children, Toronto, ON, Canada

  • Centre Leon Berard, Lyon, France

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • Children’s Healthcare of Atlanta and Aflac Cancer Center, Emory University School of Medicine, Atlanta, GA

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

  • University Children's Hospital, Robert Koch Strasse, Bonn, Germany

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • University of Alabama at Birmingham, Birmingham, AL

  • Addenbrookes Hospital, Cambridge, United Kingdom

  • Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved